Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2000-7-31
pubmed:abstractText
To evaluate the intraocular safety of an immunoconjugate (MDX-RA) developed to prevent posterior capsule opacification (PCO) in human eyes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0886-3350
pubmed:author
pubmed:issnType
Print
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
716-21
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10831902-Aged, pubmed-meshheading:10831902-Aged, 80 and over, pubmed-meshheading:10831902-Antibodies, Monoclonal, pubmed-meshheading:10831902-Capsulorhexis, pubmed-meshheading:10831902-Cataract, pubmed-meshheading:10831902-Cell Count, pubmed-meshheading:10831902-Double-Blind Method, pubmed-meshheading:10831902-Epithelial Cells, pubmed-meshheading:10831902-Female, pubmed-meshheading:10831902-Humans, pubmed-meshheading:10831902-Immunotoxins, pubmed-meshheading:10831902-Lens, Crystalline, pubmed-meshheading:10831902-Lens Capsule, Crystalline, pubmed-meshheading:10831902-Lens Implantation, Intraocular, pubmed-meshheading:10831902-Male, pubmed-meshheading:10831902-Phacoemulsification, pubmed-meshheading:10831902-Polymethyl Methacrylate, pubmed-meshheading:10831902-Prospective Studies, pubmed-meshheading:10831902-Ricin, pubmed-meshheading:10831902-Safety
pubmed:year
2000
pubmed:articleTitle
Double-masked prospective ocular safety study of a lens epithelial cell antibody to prevent posterior capsule opacification.
pubmed:affiliation
The Eye Department, St. Thomas' Hospital, London, United Kingdom.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't